Frank Zavrl's most recent trade in CervoMed Inc was a trade of 5,750 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 14, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
CervoMed Inc | Frank Zavrl | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 5,750 | 5,750 | - | - | Stock Option (Right to Buy) | |
Puma Biotechnology Inc | Frank Zavrl | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2020 | 25,748 | 50,993 (0%) | 0% | 0 | COMMON STOCK |